Meet ProJect Pharmaceutics at CPhI 2018 Read More » September 30, 2018 ProJect Pharmaceutics enters into collaboration with business partners in Asia Read More » July 1, 2018 Meet ProJect Pharmaceutics at BIO 2018 Read More » June 1, 2018 Formulation and lyophilization process development for live virus vaccines Read More » February 22, 2018 ProJect Pharmaceutics enters collaboration with German CMO as the preferred development partner for lyophilization Read More » September 19, 2017 Join ProJect Pharmaceutics at the upcoming World ADC Read More » January 30, 2017 High Protein Concentration Formulations Read More » October 29, 2015 Meet ProJect Pharmaceutics at Bio Korea 2015 Read More » March 27, 2015 Join Project Pharmaceutics at the upcoming World ADC Read More » January 31, 2014 ProJect Pharmaceutics and TUM-Spin-off ImevaX announce agreement on development of pharmaceutical formulation for IMX101 Read More » December 2, 2013 Introducing formulation and lyophilization process development for cytotoxic and other highly potent drugs Read More » July 30, 2012 Joint Development of a novel lyophilized Dual Chamber Prefillable Syringe System Read More » June 5, 2012 Page1 Page2 Page3
ProJect Pharmaceutics enters into collaboration with business partners in Asia Read More » July 1, 2018
Formulation and lyophilization process development for live virus vaccines Read More » February 22, 2018
ProJect Pharmaceutics enters collaboration with German CMO as the preferred development partner for lyophilization Read More » September 19, 2017
ProJect Pharmaceutics and TUM-Spin-off ImevaX announce agreement on development of pharmaceutical formulation for IMX101 Read More » December 2, 2013
Introducing formulation and lyophilization process development for cytotoxic and other highly potent drugs Read More » July 30, 2012
Joint Development of a novel lyophilized Dual Chamber Prefillable Syringe System Read More » June 5, 2012